In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beiersdorf first half

This article was originally published in The Rose Sheet

Executive Summary

Strong Nivea sales led Beiersdorf's Cosmed division to 6.1% sales increase to $1.61 bil. (€1=$.98) in the six months ended June 30, German company announces during in 1an Aug. 13 release. Nivea For Men skin care generated 20.6% higher in sales, while Nivea deodorant grew 14.6% on a global basis, firm notes. Cosmed earnings before interest and taxes rose slightly to $226 mil. Division sales in the Americas fell 10.6% due to economic instability in Argentina, Brazil and Mexico and the weaker U.S. dollar, company notes. Beiersdorf's consolidated sales for the first six months of the year increased 3.3% to $2.41 bil., and earnings before interest and taxes increased 3.3% to $254.3 mil., excluding income from the sale of firm's advanced wound care business...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010549

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel